Extens

Extens is a private equity firm that executes buyout and growth-equity transactions exclusively in healthcare-software companies. It targets B2B software publishers operating across clinical, administrative, and patient-engagement verticals, including occupational health, mental health, cardiology, and clinical-trial data capture. The firm pursues majority stakes and supports organic and acquisition-driven consolidation strategies.

No. Extens's public positioning, portfolio, and website disclosures indicate an exclusive commitment to healthcare-software companies. Its portfolio companies serve sub-sectors from hospital HR administration to anesthesia information systems, but all share a common thread as regulated, B2B software publishers within the broader health ecosystem.

Extens has historically concentrated on France, where its entire disclosed portfolio was based until 2024. In late 2024, the firm completed a majority acquisition of Medicore, a Dutch healthcare-software company, signaling an expansion into the Benelux region. No additional geographical mandates have been confirmed.

The firm has not published a formal investment committee roster or detailed biographies of all managing partners. In 2025, Charles Bourgain and Morgane Decultieux were promoted to Executive Director, indicating they hold senior roles likely involved in investment decisions. The firm's website describes a team with more than a decade of experience in the e-health ecosystem.

The website mentions both buyout and expansion/growth-stage strategies. While buyout appears predominant—evidenced by majority acquisitions of companies like Imagine Human and Medicore—the inclusion of 'Expansion / Late Stage' as a strategy suggests willingness to structure minority or growth-oriented transactions when the opportunity aligns with its healthcare-IT thesis.